Cargando…

Correction: Pathology-specific experimental antivenoms for haemotoxic snakebite: The impact of immunogen diversity on the in vitro cross-reactivity and in vivo neutralisation of geographically diverse snake venoms

Detalles Bibliográficos
Autores principales:	Alomran, Nessrin, Alsolaiss, Jaffer, Albulescu, Laura-Oana, Crittenden, Edouard, Harrison, Robert A., Ainsworth, Stuart, Casewell, Nicholas R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162300/ https://www.ncbi.nlm.nih.gov/pubmed/35653339 http://dx.doi.org/10.1371/journal.pntd.0010511

Ejemplares similares

Pathology-specific experimental antivenoms for haemotoxic snakebite: The impact of immunogen diversity on the in vitro cross-reactivity and in vivo neutralisation of geographically diverse snake venoms
por: Alomran, Nessrin, et al.
Publicado: (2021)

Exploring the Utility of Recombinant Snake Venom Serine Protease Toxins as Immunogens for Generating Experimental Snakebite Antivenoms
por: Alomran, Nessrin, et al.
Publicado: (2022)

The paraspecific neutralisation of snake venom induced coagulopathy by antivenoms
por: Ainsworth, Stuart, et al.
Publicado: (2018)

Exploring the Utility of ssDNA Aptamers Directed against Snake Venom Toxins as New Therapeutics for Snakebite Envenoming
por: Alomran, Nessrin, et al.
Publicado: (2022)

Haemotoxic snake venoms: their functional activity, impact on snakebite victims and pharmaceutical promise
por: Slagboom, Julien, et al.
Publicado: (2017)

Commercial Antivenoms Exert Broad Paraspecific Immunological Binding and In Vitro Inhibition of Medically Important Bothrops Pit Viper Venoms
por: Alsolaiss, Jaffer, et al.
Publicado: (2022)

In Vitro Immunological Cross-Reactivity of Thai Polyvalent and Monovalent Antivenoms with Asian Viper Venoms
por: Chaisakul, Janeyuth, et al.
Publicado: (2020)

Profiling the Murine Acute Phase and Inflammatory Responses to African Snake Venom: An Approach to Inform Acute Snakebite Pathology
por: Alsolaiss, Jaffer, et al.
Publicado: (2022)

A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite
por: Albulescu, Laura-Oana, et al.
Publicado: (2020)

Author Correction: A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite
por: Albulescu, Laura-Oana, et al.
Publicado: (2021)

Neutralising effects of small molecule toxin inhibitors on nanofractionated coagulopathic Crotalinae snake venoms
por: Xie, Chunfang, et al.
Publicado: (2020)

Preclinical antivenom-efficacy testing reveals potentially disturbing deficiencies of snakebite treatment capability in East Africa
por: Harrison, Robert A., et al.
Publicado: (2017)

Correction: Preclinical antivenom-efficacy testing reveals potentially disturbing deficiencies of snakebite treatment capability in East Africa
por: Harrison, Robert A., et al.
Publicado: (2020)

Antivenom Neutralization of Coagulopathic Snake Venom Toxins Assessed by Bioactivity Profiling Using Nanofractionation Analytics
por: Xie, Chunfang, et al.
Publicado: (2020)

Virus-like particles displaying conserved toxin epitopes stimulate polyspecific, murine antibody responses capable of snake venom recognition
por: Menzies, Stefanie K., et al.
Publicado: (2022)

Cross-Neutralisation of In Vitro Neurotoxicity of Asian and Australian Snake Neurotoxins and Venoms by Different Antivenoms
por: Silva, Anjana, et al.
Publicado: (2016)

A Review of the Proteomic Profiling of African Viperidae and Elapidae Snake Venoms and Their Antivenom Neutralisation
por: Offor, Benedict C., et al.
Publicado: (2022)

The Search for Natural and Synthetic Inhibitors That Would Complement Antivenoms as Therapeutics for Snakebite Envenoming
por: Gutiérrez, José María, et al.
Publicado: (2021)

Two snakebite antivenoms have potential to reduce Eswatini’s dependency upon a single, increasingly unavailable product: Results of preclinical efficacy testing
por: Menzies, Stefanie K., et al.
Publicado: (2022)

Immunological Cross-Reactivity and Neutralisation of European Viper Venoms with the Monospecific Vipera berus Antivenom ViperaTAb
por: Casewell, Nicholas R., et al.
Publicado: (2014)

In vitro and in vivo preclinical venom inhibition assays identify metalloproteinase inhibiting drugs as potential future treatments for snakebite envenoming by Dispholidus typus
por: Menzies, Stefanie K., et al.
Publicado: (2022)

A Decoy-Receptor Approach Using Nicotinic Acetylcholine Receptor Mimics Reveals Their Potential as Novel Therapeutics Against Neurotoxic Snakebite
por: Albulescu, Laura-Oana, et al.
Publicado: (2019)

Diversity of Micrurus Snake Species Related to Their Venom Toxic Effects and the Prospective of Antivenom Neutralization
por: Tanaka, Gabriela D., et al.
Publicado: (2010)

Biogeographic venom variation in Russell’s viper (Daboia russelii) and the preclinical inefficacy of antivenom therapy in snakebite hotspots
por: Senji Laxme, R. R., et al.
Publicado: (2021)

A Genus-Wide Bioactivity Analysis of Daboia (Viperinae: Viperidae) Viper Venoms Reveals Widespread Variation in Haemotoxic Properties
por: op den Brouw, Bianca, et al.
Publicado: (2021)

In Vitro Toxicity of Chinese Russell’s Viper (Daboia siamensis) Venom and Neutralisation by Antivenoms
por: Lay, Mimi, et al.
Publicado: (2022)

Evaluation of the geographical utility of Eastern Russell’s viper (Daboia siamensis) antivenom from Thailand and an assessment of its protective effects against venom-induced nephrotoxicity
por: Chaisakul, Janeyuth, et al.
Publicado: (2019)

Diversity of Phospholipases A(2) from Bothrops atrox Snake Venom: Adaptive Advantages for Snakes Compromising Treatments for Snakebite Patients
por: Sousa, Leijiane F., et al.
Publicado: (2022)

An analysis of preclinical efficacy testing of antivenoms for sub-Saharan Africa: Inadequate independent scrutiny and poor-quality reporting are barriers to improving snakebite treatment and management
por: Ainsworth, Stuart, et al.
Publicado: (2020)

Situation of snakebite, antivenom market and access to antivenoms in ASEAN countries
por: Patikorn, Chanthawat, et al.
Publicado: (2022)

Cross Neutralization of Afro-Asian Cobra and Asian Krait Venoms by a Thai Polyvalent Snake Antivenom (Neuro Polyvalent Snake Antivenom)
por: Leong, Poh Kuan, et al.
Publicado: (2012)

Neutralizing Effects of Small Molecule Inhibitors and Metal Chelators on Coagulopathic Viperinae Snake Venom Toxins
por: Xie, Chunfang, et al.
Publicado: (2020)

In Vitro Efficacy of Antivenom and Varespladib in Neutralising Chinese Russell’s Viper (Daboia siamensis) Venom Toxicity
por: Lay, Mimi, et al.
Publicado: (2023)

Children and Snakebite: Snake Venom Effects on Adult and Paediatric Plasma
por: Zdenek, Christina N., et al.
Publicado: (2023)

What killed Karl Patterson Schmidt? Combined venom gland transcriptomic, venomic and antivenomic analysis of the South African green tree snake (the boomslang), Dispholidus typus
por: Pla, Davinia, et al.
Publicado: (2017)

Cost of Manufacturing for Recombinant Snakebite Antivenoms
por: Jenkins, Timothy Patrick, et al.
Publicado: (2020)

Antibodies as Snakebite Antivenoms: Past and Future
por: Dias da Silva, Wilmar, et al.
Publicado: (2022)

Is anti‐snake venom required for all snakebites: A case report
por: Dorji, Thinley
Publicado: (2019)

Antivenoms for Snakebite Envenoming: What Is in the Research Pipeline?
por: Alirol, Emilie, et al.
Publicado: (2015)

Cost-effectiveness of Antivenoms for Snakebite Envenoming in Nigeria
por: Habib, Abdulrazaq G., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_f9d4jkui0m25ju3l39fk7509g4